Plain-English translation of NCT07705269 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether dialysis patients hospitalized with dangerous fluid buildup can safely undergo faster fluid removal during their dialysis treatment. Doctors currently follow conservative guidelines to remove fluid slowly to avoid blood pressure drops, but this study uses ultrasound imaging to check if patients with very congested blood vessels can tolerate faster removal rates. The goal is to relieve severe symptoms like dangerous shortness of breath more quickly and effectively.
Hospitalized dialysis patients with severe fluid overload desperately need rapid relief from symptoms like life-threatening shortness of breath, but current practice varies widely without strong scientific evidence for whether faster removal is safe. This treatment aims to find out whether personalized ultrasound guidance can safely guide faster fluid removal in patients who can tolerate it.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either standard-rate fluid removal (10 mL/kg/h) or faster fluid removal (over 13 mL/kg/h, up to 15 mL/kg/h) during your first in-hospital dialysis session. Over the first 24 hours, doctors will closely monitor your blood pressure to ensure safety, and measure changes in your ultrasound congestion scores, shortness of breath, and oxygen needs to assess whether the faster removal works better. The study compares how well each approach relieves your symptoms without causing dangerous blood pressure drops.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Mexico